Literature DB >> 16918362

Inhibitors of protein: geranylgeranyl transferases.

Farid El Oualid1, Louis H Cohen, Gijs A van der Marel, Mark Overhand.   

Abstract

The enzyme protein:geranylgeranyl transferase-1 (PGGT-1 or GGTase-I) catalyzes the geranylgeranylation of cysteine residues near the C-termini of a variety of proteins, including most monomeric GTP binding precursor proteins belonging to the Rho, Rac and Rap subfamilies. These proteins are involved in signaling pathways controlling important processes such as cell differentiation and growth. In the framework of the development of therapeutics against disorders associated with aberrant cell proliferation, the interference with these signal transduction cascades has been a major focus of investigation. For instance inhibitors of PGGT-1 have shown promise in the treatment of cancer, smooth muscle hyperplasia as well as parasitic infections, such as malaria. In this review, structural and mechanistic aspects of the protein:geranylgeranyl transferases are discussed as well as their importance with respect to the terpene metabolism. An extensive summary of reported inhibitors of PGGT-1, classified as natural products, peptide substrate (Ca(1)a(2)L box), terpene substrate (geranylgeranyl pyrophosphate) and others, is presented. The few known inhibitors of the other geranylgeranylating enzyme, protein:geranylgeranyl transferase-2 (PGGT-2), are also included.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918362     DOI: 10.2174/092986706777935078

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer.

Authors:  Meng Liu; Anna-Karin M Sjogren; Christin Karlsson; Mohamed X Ibrahim; Karin M E Andersson; Frida J Olofsson; Annika M Wahlstrom; Martin Dalin; Huiming Yu; Zhenggang Chen; Shao H Yang; Stephen G Young; Martin O Bergo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

2.  GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer.

Authors:  Anna-Karin M Sjogren; Karin M E Andersson; Meng Liu; Briony A Cutts; Christin Karlsson; Annika M Wahlstrom; Martin Dalin; Carolyn Weinbaum; Patrick J Casey; Andrej Tarkowski; Birgitta Swolin; Stephen G Young; Martin O Bergo
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

3.  Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.

Authors:  Shuzhen Chen; Lei Fu; Shruti M Raja; Ping Yue; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer       Date:  2010-01-29       Impact factor: 27.401

4.  Exploration of GGTase-I substrate requirements. Part 2: Synthesis and biochemical analysis of novel saturated geranylgeranyl diphosphate analogs.

Authors:  Kayla J Temple; Elia N Wright; Carol A Fierke; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2016-06-15       Impact factor: 2.823

5.  Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation.

Authors:  Yuri K Peterson; Xiang S Wang; Patrick J Casey; Alexander Tropsha
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

6.  Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds.

Authors:  Masaru Watanabe; Hannah D G Fiji; Lea Guo; Lai Chan; Sape S Kinderman; Dennis J Slamon; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

7.  Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification.

Authors:  Patrick J Roberts; Natalia Mitin; Patricia J Keller; Emily J Chenette; James P Madigan; Rachel O Currin; Adrienne D Cox; Oswald Wilson; Paul Kirschmeier; Channing J Der
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

8.  Quantitative determination of geranyl diphosphate levels in cultured human cells.

Authors:  Sarah A Holstein; Huaxiang Tong; Craig H Kuder; Raymond J Hohl
Journal:  Lipids       Date:  2009-10-24       Impact factor: 1.880

9.  Triazole-based inhibitors of geranylgeranyltransferase II.

Authors:  Xiang Zhou; Sara V Hartman; Ella J Born; Jacqueline P Smits; Sarah A Holstein; David F Wiemer
Journal:  Bioorg Med Chem Lett       Date:  2012-12-01       Impact factor: 2.823

10.  In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I.

Authors:  Jie Lu; Lai Chan; Hannah D G Fiji; Russell Dahl; Ohyun Kwon; Fuyuhiko Tamanoi
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.